The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

What was new in aggressive NHL at ASCO and EHA 2020?

Jun 24, 2020

The Lymphoma Hub was delighted to host an interview with Ulrich Jäger, Medical University of Vienna, Vienna, AT. We asked, What was new in aggressive non-Hodgkin lymphoma at this year's American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) virtual meetings?

This interview outlines three main fields of development:

  1. Chimeric antigen receptor (CAR) T-cell therapies
  2. CD19/CD22 bicistronic CARs
  3. Bispecific antibodies

What was new in aggressive NHL at ASCO and EHA 2020?